[Factors related to adjuvant ovarian function suppression in premenopausal breast cancer patients].

医学 依西美坦 三苯氧胺 乳腺癌 内科学 妇科 肿瘤科 佐剂 癌症
作者
Yue Liang,Xiaosong Chen,Jiayi Wu,Ou Huang,Yu Zong,Lijing Nie,Qiong Fang,Jian-Rong He,Li Zhu,Weiguo Chen,Yafen Li,Kunwei Shen
出处
期刊:Chinese journal of oncology [BioMed Central]
卷期号:38 (5): 357-62
标识
DOI:10.3760/cma.j.issn.0253-3766.2016.05.007
摘要

To analyze the applied condition of ovary function suppression (OFS) before and after joint analysis of TEXT and SOFT trials and SOFT trial, and to identify the relevant factors of OFS usage.The analysis was performed in premenopausal women with hormone receptor (HR) positive breast cancer receiving surgical treatment from Apr 2013 to Oct 2015 in Ruijin Hospital, Shanghai Jiaotong University School of Medicine. Adjuvant treatment strategy was made in the multidisciplinary team (MDT) meetings. We analyzed the applied condition of OFS before and after joint analysis, SOFT trial and its relevant factors.Among 454 patients, 114 (25.1%) patients received OFS. Before the results of joint analysis came out, all the patients (38/38) received OFS together with tamoxifen (TAM); after the results came out, clinicians began to put OFS with exemestane into practice, among 76 patients, 41(53.9%) patients received OFS with exemestane while 35 (46.1%) patients received OFS together with TAM. Before the results of SOFT trial came out, 71 out of 310 (22.9%) patients received OFS while 43 out of 144 (29.9%) patients received OFS after that. No significant difference was found between the proportion of patients receiving OFS before and after the results of SOFT trial came out (P=0.112). Age, histological grade, pN status, Ki-67 status, molecular subtype and acceptance of chemotherapy were correlated with OFS treatment (P<0.05). Age, tumor grade and pN were independent significant predictors of OFS usage.After the results of joint analysis came out, clinicians began to apply OFS with exemestane to premenopausal women with HR positive breast cancer. There is no significant difference between the proportion of patients receiving OFS before and after SOFT trial. Age, tumor grade and pN status are independent significant predictors of OFS treatment. Patients younger than 40, with histological grade Ⅱ or Ⅲ tumor and with pN1 or pN2 status are prone to receive OFS.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
凤羽发布了新的文献求助10
刚刚
灵巧听露发布了新的文献求助10
刚刚
可爱的函函应助猫猫无敌采纳,获得10
2秒前
量子星尘发布了新的文献求助10
2秒前
3秒前
4秒前
爆米花应助刁弘睿采纳,获得10
4秒前
4秒前
4秒前
缥缈海云完成签到,获得积分10
4秒前
5秒前
斯文败类应助沙场秋点兵采纳,获得10
6秒前
123完成签到,获得积分10
6秒前
7秒前
无辜问玉发布了新的文献求助10
7秒前
7秒前
8秒前
谨慎乐安发布了新的文献求助10
8秒前
10秒前
量子星尘发布了新的文献求助10
11秒前
缥缈海云发布了新的文献求助10
11秒前
mylaodao发布了新的文献求助10
11秒前
12秒前
chen完成签到,获得积分10
13秒前
拾贰月发布了新的文献求助10
13秒前
俊杰完成签到,获得积分10
14秒前
阿菜完成签到,获得积分10
14秒前
wanghao完成签到,获得积分20
14秒前
善学以致用应助songjiatian采纳,获得10
15秒前
16秒前
16秒前
善学以致用应助追忆淮采纳,获得10
17秒前
Hello应助靓丽凝海采纳,获得10
17秒前
17秒前
毛笑冉完成签到,获得积分10
17秒前
fine发布了新的文献求助10
17秒前
18秒前
无辜问玉完成签到,获得积分10
19秒前
19秒前
CodeCraft应助SJW采纳,获得10
20秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Clinical Microbiology Procedures Handbook, Multi-Volume, 5th Edition 2000
The Cambridge History of China: Volume 4, Sui and T'ang China, 589–906 AD, Part Two 1000
The Composition and Relative Chronology of Dynasties 16 and 17 in Egypt 1000
Russian Foreign Policy: Change and Continuity 800
Real World Research, 5th Edition 800
Qualitative Data Analysis with NVivo By Jenine Beekhuyzen, Pat Bazeley · 2024 800
热门求助领域 (近24小时)
化学 材料科学 生物 医学 工程类 计算机科学 有机化学 物理 生物化学 纳米技术 复合材料 内科学 化学工程 人工智能 催化作用 遗传学 数学 基因 量子力学 物理化学
热门帖子
关注 科研通微信公众号,转发送积分 5718021
求助须知:如何正确求助?哪些是违规求助? 5250051
关于积分的说明 15284272
捐赠科研通 4868198
什么是DOI,文献DOI怎么找? 2614063
邀请新用户注册赠送积分活动 1563973
关于科研通互助平台的介绍 1521425